key: cord-0843963-w2mfw01y
authors: Groothof, Dion; Post, Adrian; Gans, Reinold O B; Bakker, Stephan J L
title: Reduced Vitamin K Status and Coronavirus Disease 2019: An Epiphenomenon of Impaired Kidney Function?
date: 2021-02-25
journal: Clin Infect Dis
DOI: 10.1093/cid/ciab164
sha: 2906b7bc9d57f8f5af6fc41544176167151d3ebb
doc_id: 843963
cord_uid: w2mfw01y

nan

A c c e p t e d M a n u s c r i p t Dear Editor, Dofferhoff et al. [1] recently hypothesized that enhanced thrombogenicity related to low vitamin K status is implicated in coronavirus disease 2019 (COVID-19), linking pulmonary and thromboembolic disease. This hypothesis was corroborated by the finding of markedly elevated plasma dp-ucMGPa marker of poor extrahepatic vitamin K statusin hospitalized patients with COVID-19 compared with healthy controls. Furthermore, among patients, plasma dp-ucMGP was higher in those with poor outcome (i.e., those whom required invasive ventilation or died in-hospital) compared with good outcome (i.e., those whom were discharged without the need for invasive ventilation). These differences were independent of age, sex, and use of vitamin K antagonists as potential confounders.

Nonetheless, there are reasons to believe that the differences in plasma dp-ucMGP between hospitalized patients with COVID-19 and healthy controls and between poor and good outcome were driven by differences in kidney function. Impaired kidney function is common among hospitalized patients with COVID-19 and the degree of impairment strongly relates to disease severity. Acute kidney injury is experienced by 32% to 46% of patients [2, 3] , of which 80% develops within one day of hospitalization [3] . Interestingly, in the study by Dofferhof et al., three hospitalized patients with COVID-19 versus none of the healthy controls were dialysis-dependent, which may be a sign thereof.

Importantly, it has been consistently reported that there is a strong cross-sectional association between plasma dp-ucMGP and kidney function, with circulating dp-ucMGP progressively increasing for decreasing kidney function [4, 5] . In 2018, it was postulated that higher plasma dp-ucMGP is also associated with increased risk of incident chronic kidney disease (CKD) [6] . However, this study did not account for the cross-sectional association between plasma dp-ucMGP and kidney function at baseline. Indeed, a subsequent replication study showed that the prospective association between higher plasma dp-ucMGP and increased risk of incident CKD disappears if baseline kidney function is accounted for [7] .

A c c e p t e d M a n u s c r i p t Given the strong and established association between plasma dp-ucMGP and kidney function on the one hand and the high prevalence of kidney dysfunction in hospitalized patients with COVID-19 on the other hand, we postulate that the observation of elevated plasma dp-ucMGP in hospitalized patients with COVID-19 may be confounded by impaired kidney function. It is imperative to know whether the observations by Dofferhoff et al. [1] would remain statistically significant after baseline kidney function is accounted for. Otherwise, their findings should be interpreted with great caution, as the observed between-group differences in plasma dp-ucMGP could be an epiphenomenon of actual differences in kidney function. We therefore cordially invite the authors to report on the association of extrahepatic vitamin K status with accelerated elastic fiber degradation and thrombosis after having accounted for time-matched kidney function.

The authors received no specific funding for this work and declare that they have no conflicts of interest.

Reduced Vitamin K Status as a Potentially Modifiable Risk Factor of Severe Coronavirus Disease

AKI in Hospitalized Patients with COVID-19

Acute Kidney Injury in a National Cohort of Hospitalized US Veterans with COVID-19

Circulating Dephospho-Uncarboxylated Matrix Gla-Protein Is Associated with Kidney Dysfunction and Arterial Stiffness

Vitamin K Dependent Protection of Renal Function in Multi-ethnic Population Studies. EBioMedicine

Desphospho-uncarboxylated matrix Gla protein is a novel circulating biomarker predicting deterioration of renal function in the general population

Functional vitamin K status and risk of incident chronic kidney disease and microalbuminuria: a prospective general population-based cohort study

A c c e p t e d M a n u s c r i p t